Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check7 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no trial content changes are indicated on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded related topics Schizophrenia and MedlinePlus Genetics to the study page.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page's related topics section listing Schizophrenia and MedlinePlus Genetics was removed, reducing quick links to background information but not altering study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded Schizophrenia and related topics including MedlinePlus Genetics, and updated the page to Revision: v3.4.2. Removed the older government funding notice and Revision: v3.4.1.SummaryDifference0.5%

- Check43 days agoChange DetectedSystem notices about government funding status and NIH operations were added, and the page revision tag updated to 3.4.1 with 3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedNew metadata fields (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and a glossary are displayed; older estimated fields and older revision data are removed.SummaryDifference0.3%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.